Publications by authors named "Isett Laux"

Claim this Profile
P
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers.
Zev A Wainberg, Heloisa P Soares, Ravi Patel, Brian DiCarlo, David J Park, Isett Laux

Cancer Chemother Pharmacol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib.
Jonathan W Goldman, Isett Laux, Feng Chai, Ronald E Savage, Dora Ferrari

Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
Mitchell Gross, Irina Top, Isett Laux, Jonathan Katz, John Curran

Clin Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
Anjali Jain, Charles A Tindell, Isett Laux, Jacob B Hunter, John Curran

Proc Natl Acad Sci U S A· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation.
Ndaisha Slaughter, Isett Laux, Xiaolin Tu, Julian Whitelegge, Xiaoming Zhu

Clin Immunol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis